SEC Form 4 · accession 0001493152-18-010468
Rennova Health, Inc. · RNVA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Period of report
Jul 23, 2018
Accepted (ET)
Jul 25, 2018 · 4:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000931059
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series J Convertible Preferred StockF4,F1,F5,F2,F3 | $0.0017 | Jul 23, 2018 | A | 250,000 | A | Jul 23, 2018 | — | Common Stock | 147,058,824 | 250,000 | I |
Explanation of responses
- F1As of July 23, 2018. The conversion price equals the average closing price of the common stock for the 10 trading days prior to the conversion date.
- F2Based on the conversion price as of July 23, 2018.
- F3Each share of the Series J Convertible Preferred Stock has the number of votes equal to the number of shares of common stock into which it is convertible, except that, for certain specified matters, through September 30, 2018 only each share has 12,000 votes.
- F4Alcimede LLC received the shares in exchange for the cancellation of outstanding debt.
- F5The Series J Preferred Stock will remain outstanding until either converted or redeemed by the Company.
Remarks
Exhibit List - Exhibit 99 - Joint Filer Information